A month dedicated to lung cancer

Lung cancer is the 3rd^most common cancer and the^leading cause of cancer death in France.

At Caen Normandy University Hospital, a dedicated pathway is offered to patients with lung cancer. The hospital provides them with a multidisciplinary approach including prevention, diagnosis, treatment, supportive care, and clinical research to guarantee personalized care combined with preservation of quality of life.

People affected by lung cancer

In 2023 in France, the number of new cases of lung cancer was estimated at 52,777 (33,438 men and 19,339 women).

It ranks 2nd^among men and 3rd^among women.

It generally affects seniors, with a median age at diagnosis of 68 years in men and 66 years in women.

Aside from genetic and age-related risk factors, which are beyond our control, lung cancer is linked to environmental factors. Tobacco is the leading risk factor for lung and bronchial cancers, responsible for 8 out of 10 lung cancers.

Quitting smoking, even in cases of confirmed lung cancer, improves life expectancy

*Figures from the National Cancer Institute

Smoking cessation aid

Continuing to smoke in people with cancer has consequences for both their health and the treatments offered.

support from thetobacco cessation coordination unit at Caen Normandy University Hospital, combined with treatment if necessary. The initial consultation allows for an assessment of smoking habits, an evaluation of nicotine dependence, and the development of an individualized strategy tailored to the patient. Following this, personalized follow-up is implemented to support continued smoking cessation. If the treatment plan requires it, the tobacco cessation specialist can consult with the unit's dietitian and/or psychologist. Most nicotine replacement therapies are covered by Frenchnational health insurance.

The Caen Normandy University Hospital, Zero Tobacco Hospital

The management and diagnosis of lung cancer

The Pulmonology Department at Caen Normandy University Hospital offers comprehensive care for patients with lung cancer. An interdisciplinary medical and paramedical team provides daily support and coordinates their care (diagnosis, surgery, administration and monitoring of treatment within the oncology day hospital). The team also organizes inpatient stays and admissions to the Intensive Care Unit (ICU).

The team from the pulmonology department at Caen Normandy University Hospital

The hospital treats 200 new lung cancer patients annually. Care begins as soon as the disease is suspected, with patients offered a consultation appointment with a pulmonologist within 72 hours. This care is supported by an endoscopy suite and in collaboration with the thoracic surgery and pathology departments.

The diagnosis is confirmed by taking samples of the tumor, most often via bronchoscopy. This allows for precise visualization of the trachea and bronchi. Various examinations are then performed to assess the extent of the disease (CT scan, MRI, PET scan).